PEBP1 and anaplastic oligodendroglioma: In general, RKIP expression was found in 89.6% (20/193) of all the tumors, specifically in 95.2% (20/21) of astrocytomas grade II (Figure 1B), in 89.5% (128/143) of glioblastomas (Figure 1E and F), in 80% (12/15) of oligodendrogliomas grade II (Figure 1C and D), 75% (3/4) of anaplastic oligoastrocytoma, and 100% of oligoastrocytomas grade II (2/2) and anaplastic oligodendrogliomas (8/8) (Table 1).